top of page
NanoDrops_HOMEPAGE.jpg

NanoDrops’ vision correction technology empowers patients to customize their visual acuity as their vision needs evolve.

NANODROPS VISION

NanoDrops Vision

Vision correction with peace of mind for doctors and patients. 
Picture502.png

One technology.
Multiple indications.

Presbyopia is a physiological insufficiency of optical accommodation associated with the aging of the eye, it results in progressively worsening ability to focus clearly on close objects.

Addressing presbyopia as our first indication

THE PROBLEM

The Problem

Lack of a long-lasting spectacle-free solution

for the pre-cataract presbyopia patients

Lack of a long-lasting spectacle-free solution

for the pre-cataract presbyopia patients

​
Picture50.png

The Solution

The Ruby procedure: adjustable and reversible treatment for presbyopes

Imprint the customized optical pattern on the corneal surface

(transepithelial laser ablation)

Imprint the customized optical pattern on the corneal surface

(transepithelial laser ablation)

1

Filling agent is in

the channels

Filling agent is in

the channels

4

Optical pattern imprinted
on the cornea

Optical pattern imprinted
on the cornea

2

Optical pattern

is activated

Optical pattern

is activated

5

Instill filling agent drop
into the channels

Instill filling agent drop
into the channels

3

Light passage is redirected resulting
in refractive correction

Light passage is redirected resulting
in refractive correction

6

Picture502.png

Unique Value Proposition

Confidence & peace of mind: an adjustable and reversible procedure

Unique Value Proposition

2.png

Eliminates the need for reading glasses

Picture76.png

Access to Choice:

Temporary or
long-lasting solution

Picture73.png

Restoring near vision while preserving
distance vision

Picture77.png

Micro-Invasive, Extraocular:

Crystalline lens and
corneal integrity preserved

Picture74.png

Add-on kit designed for use with existing excimer lasers

Picture78.png

Keeps future options open:

Monofocal / EDOF / multifocal IOLs

Picture48.png

A Team That Has
Done This Before

Daria Lemann
  • LinkedIn
Daria Lemann-Blumenthal, LL.B., EMBA
CEO

Former CEO and Co-Founder, BELKIN Vision

Acquired by Alcon for $466M

Arik Hybloom, CPA CFO.png
  • LinkedIn
Arik Hybloom, CPA
CFO
 

Former CFO, BELKIN Vision

Director at Make a Wish

Prof. David Smadja, MD
  • LinkedIn
Prof. David Smadja, MD
Co-founder & CMO
 

Chair of the Innovation Committee of the International Society of Refractive Surgery

Keren Reuveni, M.Sc..jpg
  • LinkedIn
Keren Reuveni, M.Sc.
Clinical Affairs Director
 

MedTech Clinical Affairs Professional

Dana Leitman, M.Sc., EMBA.png
  • LinkedIn
Dana Leitman, M.Sc., EMBA
VP QA/RA

Former Head of APAC

Arcondis Group

Yifat Harel, PhD Bio-Chemical Scientist.png
  • LinkedIn
Yifat Harel, PhD
Bio-Chemical Scientist
 

Research Lab Manager,

Bar Ilan University

Eran Kaplan, M.Sc. CTO.png
  • LinkedIn
Eran Kaplan, M.Sc.
CTO
 

Former VP R&D and CEO, IOPtima

Jay Stark, MBA
  • LinkedIn
Jay Stark, MBA
Commercial Strategy Lead
 

Former leader at Alcon (18 years)

Picture50.png

Board of Directors

Assaf Barnea
  • LinkedIn
Assaf Barnea

Chairman of the Board

Managing Partner

Sanara Ventures

​David Ben Ami.png
  • LinkedIn
David Ben Ami

Director

Rick Heinick
  • LinkedIn
Rick Heinick

Founder, Solo VC

Eli Yered.png
  • LinkedIn
Eli Yered

Partner and CFO

Sanara Ventures

Prof. David Smadja, MD
  • LinkedIn
Prof. David Smadja, MD

Co-founder & CMO

Prof. Zeev Zalevsky PhD.png
  • LinkedIn
Prof. Zeev Zalevsky PhD

Dean of the Engineering Faculty in Bar Ilan University

Picture502.png

Medical Advisory Board

bottom of page